The Manila Times

Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Atopic Dermatitis (AD) with Its Novel Bispecific Antibody ATI-052

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product ...
Road to VR

Steam Reveals Most Played PC VR Games of 2025

Steam has unveiled its mega list of the most played PC VR games of 2025. And it looks to be another year of ‘old reliables’, ...
TweakTown

This new Raymarching benchmark will bring your RTX 5090 to its knees: 1080p at just 2-3FPS

The new Radiance DX12 GPU benchmark uses Raymarching, relies on FP32 compute, shows potential of current and future graphics ...

Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced it has entered into a clinical trial collaboration with GSK plc ("GSK ...

Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2…

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that it has submitted a Biologics ...
Tbreak

CoD: Mobile is starting 2026 with a massive Street Fighter crossover and new mythics

Mobile Season 1 launches on 15 January in the UAE. Here is everything you need to know about the Frozen Abyss update, the new ...
Tbreak

PUBG Mobile Peaky Blinders Collaboration: Thomas Shelby Skins & Story Mode Until 5 February

The Shelby family has arrived on the battlegrounds. Here is everything included in the PUBG Mobile x Peaky Blinders ...
The Manila Times

Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones

DMR-001, a potentially best-in-class mutant calreticulin ('mutCALR”) targeting monoclonal antibody, on track for expected IND submission, or equivalent, in mid-2026 with anticipated first-in-human ...